EDGAR Filing Documents for 0001171843-24-002427

Form 8-K - Current report:

SEC Accession No. 0001171843-24-002427

Filing Date

2024-05-01

Accepted

2024-05-01 16:30:37

Documents

Period of Report

2024-04-29

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	f8k_050124.htm iXBRL	8-K	25024
2	EXHIBIT 10.1	exh_101.htm	EX-10.1	175428
3	EXHIBIT 10.2	exh_102.htm	EX-10.2	87541
4	EXHIBIT 10.3	exh_103.htm	EX-10.3	93010
5	GRAPHIC	db_sig.jpg	GRAPHIC	30577
6	GRAPHIC	wr_sig.jpg	GRAPHIC	29232
7	GRAPHIC	rb_sig.jpg	GRAPHIC	33706
8	GRAPHIC	fp_sig.jpg	GRAPHIC	31385
	Complete submission text file	0001171843-24-002427.txt		815579

Data Files

Seq	Description	Document	Type	Size
9	XBRL SCHEMA FILE	apto-20240429.xsd	EX-101.SCH	3009
10	XBRL LABEL FILE	apto-20240429_lab.xml	EX-101.LAB	34240
11	XBRL PRESENTATION FILE	apto-20240429_pre.xml	EX-101.PRE	22355
23	EXTRACTED XBRL INSTANCE DOCUMENT	f8k_050124_htm.xml	XML	3707

Mailing Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3

Business Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3 647-479-9828

Aptose Biosciences Inc. (Filer) CIK: 0000882361 (see all company filings)